QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Launches Canadian Subsidiary, Enters Binding Agreement to Acquire Stake in Cannabis Testing Facility

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced the establishment of a new and wholly-owned subsidiary, EVIO Canada, which will serve as the parent company for EVIO’s Canadian operations. Concurrently, EVIO Canada announced today that it has entered into a binding agreement to acquire 50 percent of Keystone Labs Inc., a privately held, independent contract-testing laboratory specializing in quality testing for regulated industries located in Edmonton, Alberta. “Keystone Labs is one of 37 laboratories licensed by Health Canada and one of only three laboratories that hold both a Dealer’s License and a GMP Drug Establishment License for cannabis testing,” William Waldrop, CEO and co-founder of EVIO, stated in the news release. “This acquisition is a significant milestone for EVIO as it will mark our first foray into an international market. Our goal is to increase consumer safety and confidence, while further pursuing our aggressive expansion plans for 2018.”

To view the full press release, visit http://ibn.fm/dEYON

About EVIO, Inc.

EVIO, Inc. is a life sciences company focused on analyzing cannabis as a means for improving quality of life. The Company provides analytical testing services, advisory services and performs product research in its accredited laboratory testing facilities. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. For more information, visit www.EvioLabs.com